Yousry Esam-Eldin Abo-Amer, 1 Aisha Sabal, 2 Rehab Ahmed, 2 Nabil Fathy Esmael Hasan, 3 Rasha Refaie, 4 Sahar Mohamed Mostafa, 2 Ahmed Abdelhaleem Mohamed, 2 Mahmoud Khalil, 2 Waleed Elagawy, 5 Sherief Abd-Elsalam 6
1Hepatology, Gastroenterology and Infectious Diseases Department, Mahala Hepatology Teaching Hospital, Gharbia, Egypt; 2Hepatology, Tropical Medicine and Infectious Diseases Departments, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt; 3Clinical Pathology Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt; 4Internal Medicine Department, Helwan University, Helwan, Egypt; 5Department of Tropical Medicine, Portsaid University, Portsaid, Egypt; 6Tropical Medicine Department, Tanta University, Tanta, Egypt
Correspondence: Sherief Abd-Elsalam
Tropical Medicine Department, Tanta University, Tanta, Egypt
Tel +201063319696
Email [email protected]
Background: Non-alcoholic fatty liver disease (NAFLD) is a very common disease that affects 25– 30% of the population in western countries. Many studies have observed the importance of H. pylori infection in the development of insulin resistance, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and liver fibrosis and cirrhosis. However, the evidence from different studies was controversial. The present study aimed to investigate the relationship between H. pylori infection and NAFLD in a developing country.
Patients and Methods: This cross-sectional study included all the attending outpatient clinics at four Major University hospitals and two research and clinical institutes in a developing country in the period between June and October 2019. Patients were assessed for the diagnosis of H. pylori infection as detected by H. pylori antigen in stool; they were also assessed for the diagnosis of NAFLD by ultrasound, fibroscan, and CAP.
Results: The study was conducted on 646 patients; H. pylori infection was found to be present in 538 patients (83.3%). NAFLD (diagnosed by both U/S and Fibroscan with CAP), ALT, AST, hepatomegaly, hypertension, fasting blood sugar were significantly higher in H. pylori +ve group than H. pylori −ve group. After performing Linear regression of independent risk factors of NAFLD to prove or to refute the role of Helicobacter; H. pylori positivity, total cholesterol, degree of fatty liver by ultrasound, fasting blood sugar and diastolic blood pressure were independent risk factors for NAFLD.
Conclusion: Helicobacter pylori infection was independent risk factors for NAFLD and correlated with increased degree of steatosis.
Keywords: Helicobacter pylori, steatosis, fibrosis, NAFLD, prevalence, fibroscan
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
